Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 1
2017 1
2019 2
2020 10
2021 13
2022 10
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean laura stanberry (1 results)?
Regulatory role of CD39 and CD73 in tumor immunity.
Kaplinsky N, Williams K, Watkins D, Adams M, Stanbery L, Nemunaitis J. Kaplinsky N, et al. Among authors: stanbery l. Future Oncol. 2024 Apr 23. doi: 10.2217/fon-2023-0871. Online ahead of print. Future Oncol. 2024. PMID: 38652041 Free article. Review.
Advances in Targeted Therapy for the Treatment of Cervical Cancer.
Watkins DE, Craig DJ, Vellani SD, Hegazi A, Fredrickson KJ, Walter A, Stanbery L, Nemunaitis J. Watkins DE, et al. Among authors: stanbery l. J Clin Med. 2023 Sep 15;12(18):5992. doi: 10.3390/jcm12185992. J Clin Med. 2023. PMID: 37762931 Free PMC article. Review.
Pilot Study of Recurrent Ewing's Sarcoma Management with Vigil/Temozolomide/Irinotecan and Assessment of Circulating Tumor (ct) DNA.
Anderson P, Ghisoli M, Crompton BD, Klega KS, Wexler LH, Slotkin EK, Stanbery L, Manning L, Wallraven G, Manley M, Horvath S, Bognar E, Nemunaitis J. Anderson P, et al. Among authors: stanbery l. Clin Cancer Res. 2023 May 1;29(9):1689-1697. doi: 10.1158/1078-0432.CCR-22-2292. Clin Cancer Res. 2023. PMID: 36780200 Free PMC article.
NF-κB Signaling in Tumor Pathways Focusing on Breast and Ovarian Cancer.
Devanaboyina M, Kaur J, Whiteley E, Lin L, Einloth K, Morand S, Stanbery L, Hamouda D, Nemunaitis J. Devanaboyina M, et al. Among authors: stanbery l. Oncol Rev. 2022 Oct 3;16:10568. doi: 10.3389/or.2022.10568. eCollection 2022. Oncol Rev. 2022. PMID: 36531159 Free PMC article. Review.
Folate Receptor as a Biomarker and Therapeutic Target in Solid Tumors.
Young O, Ngo N, Lin L, Stanbery L, Creeden JF, Hamouda D, Nemunaitis J. Young O, et al. Among authors: stanbery l. Curr Probl Cancer. 2023 Feb;47(1):100917. doi: 10.1016/j.currproblcancer.2022.100917. Epub 2022 Nov 17. Curr Probl Cancer. 2023. PMID: 36508886 Free article. Review.
Corrigendum to "Gemogenovatucel-T (Vigil) immunotherapy demonstrates clinical benefit in homologous recombination proficient (HRP) ovarian cancer" [Gynecologic Oncology Volume 161, Issue 3, June 2021, Pages 676-680].
Rocconi RP, Monk BJ, Walter A, Herzog TJ, Galanis E, Manning L, Bognar E, Wallraven G, Stanbery L, Aaron P, Senzer N, Coleman RL, Nemunaitis J. Rocconi RP, et al. Among authors: stanbery l. Gynecol Oncol. 2023 Feb;169:173. doi: 10.1016/j.ygyno.2022.11.010. Epub 2022 Nov 28. Gynecol Oncol. 2023. PMID: 36456375 No abstract available.
Systemic benefit of radiation therapy via abscopal effect.
Craig DJ, Ambrose S, Stanbery L, Walter A, Nemunaitis J. Craig DJ, et al. Among authors: stanbery l. Front Oncol. 2022 Oct 25;12:987142. doi: 10.3389/fonc.2022.987142. eCollection 2022. Front Oncol. 2022. PMID: 36387120 Free PMC article.
42 results